Hostname: page-component-74656f9884-npj9w Total loading time: 0 Render date: 2026-11-07T12:53:36.720Z Has data issue: false hasContentIssue false

Valuing a Reduction in the Risk and Severity of Asthma: A Large Scale Multi-Country Stated Preference Approach

Published online by Cambridge University Press:  26 April 2024

Gildas Appéré
Affiliation:
University of Angers, Department of Economics, Angers, France
Damien Dussaux
Affiliation:
OECD, Environment Directorate, Paris, France
Alan Krupnick
Affiliation:
Resource for the Future, Washington, DC, USA
Muriel Travers*
Affiliation:
Nantes University, Department of Economics, Nantes, France
*
Corresponding author: Muriel Travers; Email: muriel.travers@univ-nantes.fr
Rights & Permissions [Opens in a new window]

Abstract

Asthma is a non-communicable and non-curable lung disease that affects 10% of children and 4% of adults worldwide and is associated with an array of environmental contaminants and chemicals. This article offers values suitable for use in cost–benefit analyses of the willingness to pay (WTP) for reduced severity of asthma in adults and children and in reduced probability of getting asthma for these two population groups, all in the context of reducing chemical exposures. To this end, an online survey was administered between November 2021 and May 2022 to 12 727 respondents from seven countries of the Organisation for Economic Co-operation and Development (OECD). This article applies two stated preference methods for eliciting WTP: the contingent valuation method for reduced asthma severity and choice experiments for reduced probability of getting asthma of various severities. The context for such elicitations was a set of household products that contain fewer hazardous chemicals than what is currently available in supermarkets but are more expensive. The study finds that the WTP for reducing asthma severity in adults by one step, e.g. from “moderate plus” to “moderate”, is USD2022 529 per year on average. The parental WTP for reducing asthma severity in their children is USD2022 PPP 948 per year and is on average 1.8 times higher than their WTP for themselves. The mean value of a statistical case (VSC) of adult asthma which would be applied to predictions of new cases of asthma avoided by a regulation equals USD2022 280 000, while the mean VSC of childhood asthma equals USD2022 430 000.

Information

Type
Article
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of Society for Benefit-Cost Analysis
Figure 0

Figure 1. Picture used to present original vs SAFETYFIRST household products.Note: Labels on products were translated in each country. Source: Authors’ own elaboration.

Figure 1

Figure 2. Branching of the asthma survey.Source: Authors’ own elaboration.

Figure 2

Figure 3. Visual description of asthma severity levels.Source: Authors’ own elaboration.

Figure 3

Figure 4. Double-bounded dichotomous choice to elicit WTP to reduce asthma severity. Source: Authors’ own elaboration.

Figure 4

Table 1. Bid values for the first dichotomous choice

Figure 5

Table 2. Bids presented to respondents in the United States, in USD per year

Figure 6

Table 3. Example of choice in the discretechoice experiment to elicit WTP to avoid developing asthma

Figure 7

Figure 5. Question to test respondents’ understanding of probability using visuals.Source: Authors’ own elaboration, following Krupnick et al. (2002).

Figure 8

Table 4. Average deviation from target quotas across surveyed countries

Figure 9

Table 5. Average absolute deviation from target quotas across key demographics

Figure 10

Table 6. Full and screened sample composition

Figure 11

Table 7. Examples of responses to open-ended from English speaking asthmatic adults and parent of asthmatic child

Figure 12

Table 8. Share of problematic responses to open-ended for asthmatic adults and children

Figure 13

Table 9. Bias direction of problematic responses to debriefing questions for asthma severity

Figure 14

Table 10. Frequency of poor answers to debriefing questions, asthmatic adults

Figure 15

Table 11. Frequency of poor answers to debriefing questions, parents of an asthmatic child

Figure 16

Table 12. Number of respondents in the screened sample by country and by group

Figure 17

Table 13. Main parametric estimations of WTP to reduce asthma severity in adults

Figure 18

Table 14. Main parametric estimations of WTP to reduce asthma severity in children

Figure 19

Figure 6. Mean and median WTP for a reduction in asthma severity in adults and children. Source: Authors’ own elaboration.

Figure 20

Table 15. The determinants of WTP to reduce asthma severity in adults

Figure 21

Table 16. The determinants of WTP to reduce asthma severity in children

Figure 22

Table 17. Country-level estimates of WTP to reduce asthma severity

Figure 23

Figure 7. WTP to reduce adult and childhood asthma severity by country. Note: Mean WTP derived from the parametric estimations reported in Table 17.Source: Authors’ own elaboration.

Figure 24

Figure 8. WTP to reduce adult asthma severity and effectiveness of health system.Note: Mean WTP derived from the parametric estimations reported in Table 17.Source: Data on preventable and treatable causes of mortality come from OECD (2019), “Avoidable mortality (preventable and treatable),” in Health at a Glance 2019: OECD Indicators, OECD Publishing, Paris, https://doi.org/10.1787/3b4fdbf2-en.

Figure 25

Figure 9. WTP to reduce adult asthma severity, GDP per capita, and medical cost burden.Note: Mean WTP derived from the parametric estimations reported in Table 17.Source: GDP per capita in 2019, PPP (constant 2017 international USD) comes from the World Bank. Data on domestic private health expenditure per capita comes from the World Health Organization Global Health Expenditure database. Data on equivalized income are taken from OECD Income Distribution Database.

Figure 26

Table 18. Estimations of WTP to reduce asthma severity in adults including debriefing controls

Figure 27

Table 19. Estimations of WTP to reduce asthma severity in children including debriefing controls

Figure 28

Table 20. Mean WTP by country depending on anticipation of medical cost savings

Figure 29

Table 21. Estimates of the LCM model for the two specifications for all countries

Figure 30

Table 22. Estimates of the LCM model excluding non-asthmatic adults from the Czech Republic

Figure 31

Table 23. Estimates of the LCM model excluding parents of non-asthmatic children from the Czech Republic

Figure 32

Figure 10. Mean marginal willingness to pay for 1 in 1 000 reduction in the risk to develop adult and childhood asthma. Note: Mean WTP is the weighted average of individual WTP where the weight equals to the sampling weight used to correct for the differences between the sample and the target population. Parents of non-asthmatic children were asked their WTP for a reduction in the risk that their youngest non-asthmatic child develops asthma.Source: Authors’ own elaboration.

Figure 33

Figure 11. Median marginal willingness to pay for 1 in 1 000 reduction in the risk to develop adult and childhood asthma. Note: Median WTP is the median of individual WTP multiplied with the sampling weight used to correct for the differences between the sample and the target population. Parents of non-asthmatic children were asked their WTP for a reduction in the risk that their youngest non-asthmatic child develops asthma.Source: Authors’ own elaboration.

Figure 34

Figure 12. Mean marginal willingness to pay for non-asthmatic adults by country.Source: Authors’ own elaboration.

Figure 35

Figure 13. Mean marginal willingness to pay of parents of non-asthmatic children for a 1 in 1 000 risk reduction in the risk that their child develops asthma.Source: Authors’ own elaboration.

Figure 36

Figure 14. Median marginal willingness to pay for non-asthmatic adults by country.Source: Authors’ own elaboration.

Figure 37

Figure 15. Median marginal willingness to pay of parents of non-asthmatic children for a 1 in 1,000 risk reduction in the risk that their child develops asthma.Source: Authors’ own elaboration.

Figure 38

Table 24. Marginal WTP for reduced asthma risk by stance on medical cost saving for asthmatic adults

Figure 39

Table 25. Estimates of the LCM model taking into account child status

Figure 40

Table 26. Recommended mean WTP values for a one-step reduction in asthma severity by surveyed country

Figure 41

Table 27. Recommended mean values of a statistical case of asthma by surveyed country

Figure 42

Table 28. Measuring the benefits of policy interventionin France: an illustrative example using the value of a statistical case of adult asthma

Figure 43

Table 29. Measuring the benefits of policy intervention in France: an illustrative example using the mean WTP to reduce adult asthma severity by one step

Supplementary material: File

Appéré et al. supplementary material

Appéré et al. supplementary material
Download Appéré et al. supplementary material(File)
File 93.4 KB